Article

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

2021-10-29

Abstract excerpt

<h4>SUMMARY</h4> The enhanced transmissibility and immune evasion associated with emerging SARS-CoV-2 variants demands the development of next-generation vaccines capable of inducing superior protection amid a shifting pandemic landscape. Since a portion of the global population harbors some level of immunity from vaccines based on the original Wuhan-Hu-1 SARS-CoV-2 sequence or natural infection, an important que...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1cb16de4-1a10-5dc5-be54-a3021f080386
DOI: 10.1101/2021.10.27.466163

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primatesDOI 10.1101/2021.10.27.466163Read

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variantsSemantic proximity Read

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 VariantsSemantic proximity Read

Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adultsSemantic proximity Read

mRNA booster vaccination protects extremely aged mice against the SARS-CoV-2 Omicron variantSemantic proximity Read

Dynamics of Temporal Immune Responses in Nonhuman Primates and Humans Immunized with COVID-19 VaccinesSemantic proximity Read

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceSemantic proximity Read

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccineSemantic proximity Read

Vaccine protection against the SARS-CoV-2 Omicron variant in macaquesSemantic proximity Read

Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman PrimatesSemantic proximity Read

Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys.Semantic proximity Read

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primatesSemantic proximity Read

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesSemantic proximity Read